Jordan Health Services Location: 1502 10th Street Ste B, Bridgeport, Texas 76426 Ratings: Phone: (940) 683-6370 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Elara Caring Location: 1502 10th Street Suite C, Bridgeport, Texas 76426 Ratings:NA Phone: (940) 442-5302 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Home Health Care Of North Central Texas Inc Location: 401 Center Ct, Bridgeport, Texas 76426 Ratings: Phone: (940) 683-3300 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
News Archive
ZeOmega, a premier provider of care management software solutions and services, today announced its strategic alliance with Eldorado Computing Inc. (ELDORADO), an MphasiS Company and a leading provider of health benefit and claims management platforms, to offer an integrated care and benefits management solution.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the publication of preclinical data in the Journal of Neuroimmunology finding that its lead development candidate VB-201 significantly delayed the onset and severity of experimental autoimmune encephalomyelitis (EAE) in mice, the commonly used Multiple sclerosis.
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 94 new national research and training grants totaling $45,097,000 to 61 institutions nationwide in the second of two grants cycles for 2009. The grants go into effect beginning January 1, 2010.
Eli Lilly and Company today announced that the primary endpoints, both cognitive and functional, were not met in either of the two Phase 3, double-blind, placebo-controlled solanezumab EXPEDITION trials in patients with mild-to-moderate Alzheimer's disease.
› Verified 2 days ago